Roundup /Glyphosate

Roundup Linked to Several Types of Cancer

Cancer linked to Roundup® Include:

  • Non-Hodgkin Lymphoma
  • B Cell or T Cell Non-Hodgkin Lymphoma
  • Follicular Lymphoma
  • Chronic Lymphotic Leukemia
  • Other Non-Hodgkin Lymphoma Cancer Types

Roundup® / Glyphosate

Roundup® is a popular weedkiller used both by individuals and larger corporations for commercial purposes. herbicide that was developed by Monsanto Company and introduced to the consumer market in 1974. At present, Roundup® is the best-selling herbicide in the world. Individuals who have had prolonged usage of and exposure to Roundup® have filed thousands of lawsuits against Monsanto claiming that their exposure to the active ingredient in Roundup®, glyphosate, is linked to their development of a specific type of cancer called Non-Hodgkin Lymphoma (NHL).


Common Occupations with Roundup® Exposure

  • Farm and Agricultural
  • Garden and Nursery
  • Grounds Maintenance
  • Golf Course Crews
  • Landscapers
  • Sports and Turf Management
  • Lawn Care

Cancer Linked to Repeated Exposure to Roundup®

  • Breathing Roundup® in while spraying, mixing, etc.
  • Contact with Roundup® on your skin.
  • Ingesting Roundup® by drinking water or eating food that is contaminated.

About Monsanto Roundup®

As mentioned before, Roundup® is an herbicide developed and sold by the Monsanto Company beginning roughly 45 years ago. For decades, this substance has been utilized as a weed killer by individuals in both commercial and private settings. The active ingredient in Roundup® is a common herbicidal chemical called glyphosate.

In 2015, the Monsanto Company generated just shy of $2 billion in gross profits from sales of the herbicide. Though there are other companies that sell generic versions of the Roundup® herbicide containing the ingredient glyphosate, Roundup, and thus Monsanto, continue to dominate the market.

Roundup® Linked to Cancer

In 2015, the International Agency for Research on Cancer (IARC), the cancer-research focused division of the World Health Organization (WHO), issued a report officially classifying the chemical compound glyphosate as “probably carcinogenic to humans.” The report further states:

“Two large case-control studies of NHL [Non-Hodgkin Lymphoma] from Canada and the USA, and two case-control studies from Sweden reported statistically significant increased risks of NHL in association with exposure to glyphosate.”

There are thousands of people across the United States that have been diagnosed with Non-Hodgkin Lymphoma after prolonged exposure to Roundup®. Though Roundup® is primarily used and handled by agricultural workers and gardeners, there is also potential for runoff to have developed concentrations of the chemical in agricultural workplaces, food, and drinking water. If you or a loved one have experienced any symptoms of Non-Hodgkin Lymphoma, you should seek medical attention right away.

Non-Hodgkin Lymphoma is often accompanied by the following symptoms:

  • ·         Painless, swollen lymph nodes
  • Abdominal pain or swelling
  • Chest pain or trouble breathing
  • Persistent Fatigue
  • Night sweats
  • Unexplained weight loss

If you think you may have developed Non-Hodgkin Lymphoma, do not wait to get diagnosed. This type of cancer is treatable with early detection.


Roundup® and Glyphosate Lawsuits

For decades, the Monsanto Company has maintained their stance that Roundup® is safe to use despite numerous studies having identified significant links between Roundup and Non-Hodgkin Lymphoma. There are currently hundreds of pending lawsuits against the Monsanto Company related to this chemical, and they are claiming that the company failed to warn Roundup® users of the increased risk of developing Non-Hodgkin Lymphoma.

The following are two of the most notable lawsuits involving Roundup® weed killer. It is important to note that the Hardeman case was only the second Roundup® lawsuit (of thousands) to go to trial in the United States.

Notable Roundup® Cases

  • In 2014, California school groundskeeper Dewayne Johnson was diagnosed with Non-Hodgkin Lymphoma. He later, aided by his attorney, filed a lawsuit against the Monsanto Company alleging prolonged use of Roundup Pro® and Ranger Pro® glyphosate-based herbicides caused his cancer. In August 2018, the jury presents their verdict in favor of Johnson, awarding him $39 million in compensatory and $250 million in punitive damages, totaling $289 million. The award was later reduced to $78 million.
  • In 2015, Edwin Hardeman was diagnosed with Non-Hodgkin Lymphoma. Hardeman had used Roundup® weed killer for tending to his property for over two decades. Hardeman, aided by his attorney, filed a lawsuit against the Monsanto Company, and it was determined by the jury that both the weed killer was a “substantial factor” in causing Hardeman’s cancer, and that Monsanto demonstrated negligence and should be held liable. In March 2019, the federal jury awarded Hardeman $5 million in compensatory and $75 million in punitive damages, totaling $80 million.

Have You Been Exposed To Roundup® and Later Developed Cancer?

At Stokes Stemle we understand that a cancer diagnosis can have devastating effects on an individual and those who care for him or her. If you have been diagnosed with Non-Hodgkin Lymphoma after prolonged or extensive exposure to Roundup® please call Stokes Stemle today and let one of our experienced Roundup® lawsuit attorneys help you today.

Call Stokes Stemle – Personal Injury Attorneys and let our experienced and dedicated attorneys at fight for you or your loved one. We work around the clock to ensure our clients are not on the hook for insurmountable medical bills and are properly compensated for their pain and suffering. We need to review your case and answer any questions that you may have. Call us today at (334) 316-4123 and have your case reviewed free of charge right now. You may also contact us by completing the Free Consultation Form OR come by one of our offices located in Auburn, Dothan and Montgomery.

Free Case Evaluation

  • This field is for validation purposes and should be left unchanged.